[1]
|
Buerger, L. (1952) Thrombo-angiitis obliterans: A study of the vascular lesions leading to presenile spontaneous gangrene. American Journal of Medicine, 13(5), 526- 532.
|
[2]
|
Brodmann, M., Renner, W., Stark, G., Winkler, M., Pabst, E., Hofmann, C. and Pilger, E. (2000) Prothrombotic risk factors in patients with thrombangitis obliterans. Thrombosis Research, 99(5), 483-486.
|
[3]
|
Cooper, L.T., Tse, T.S., Mikhail, M.A., Mcbane, R.D., Stanson, A.W. and Ballman, K.V. (2004) Long-term survival and amputation risk in thromboangiitis obliterans (Buerger’s disease). Journal of the American College of Cardiology, 44(12), 2410-2411.
|
[4]
|
Taşoğlu, I., Hanedan, O. and Ulus, A.T. (2008) Thromboangiitis obliterans (buerger hastalığı). Turkiye Klinikleri Journal of General Surgery Special Topics, 1(3), 15- 25.
|
[5]
|
Szuba, A. and Cooke, J.P. (1998) Thromboangiitis obliterans. An update on Buerger’s disease. Western Journal of Medicine, 168(4), 255-260.
|
[6]
|
Özen, F., Manduz, Ş., Katrancıoğlu, N., Karahan, O., Köksal, B. and Özdemir, Ö. (2009) Tromboanjiitis obliterans hastalarında protrombotik gen polimorfizminin rolü turkiye klinikleri. Journal of Cardiovascular Science, 21(2), 160-164.
|
[7]
|
Isserhoff, R.R. and Rifkin, D.B. (1983) Plasminogen is present in the basal layer of the epidermis. Journal of Investigative Dermatology, 80, 297-299.
|
[8]
|
Herouy, Y., Trefzer, D., Hellstern, M.O., Stark, G.B., Vanscheıdt, W., Schoè, P.F.E. and Norgauer J. (2000) Plasminogen activation in venous leg ulcers. British Journal of Dermatology, 143(5), 930-936.
|
[9]
|
Isordia-Salas, I., Leaños-Miranda, A., Sainz, I.M., Reyes- Maldonado, E. and Borrayo-Sánchez, G. (2009) Association of the plasminogen activator inhibitor-1 gene 4G/5G polymorphism with ST elevation acute myocardial infarction in young patients. Revista Española de Cardiología, 62(4), 365-372.
|
[10]
|
Foley, S. and Gibbs, H. (2008) Muir painful digital infarction in a male smoker treated as Buerger’s disease. Australasian Journal of Dermatology, 49(2), 94-97.
|
[11]
|
Stammler, F., Diehm, C., Hsu, E., Stockinger, K. and Amendt, K. (1996) The prevalence of hyperhomocysteinemia in thrombangitis obliterans. Does homocsteine play a role pathogenetically? Deutsche medizinische Wochenschrift, 121(46), 1417-1423.
|
[12]
|
Chenl, Z., Takahashi, M., Naruse, T., Nakajima, T., Chen, Y.W., Inoue, Y., Ishikawa, I., Iwail, T. and Kimura, A. (2007) Synergistic contribution of CD14 and HLA loci in the susceptibility to Buerger disease. Human Genetics, 122(3-4), 367-372.
|
[13]
|
Yenicesu, G.I., Cetin, M., Ozdemir, O., Cetin, A., Ozen, F., Yenicesu, C., Yildiz, C. and Kocak, N. (2009) A prospective case-control study analyzes 12 thrombophilic gene mutations in turkish couples with recurrent pregnancy loss. American Journal of Reproductive Immuno- logy, 63(2), 126-136.
|
[14]
|
Abboud, N., Ghazouani, L., Saidi, S., Ben-Hadj-Khalifa, S., Addad, F., Almawi, W.Y. and Mahjoub, T. (2010) Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: A case-control study. Genetic Testing and Molecular Biomarkers, 14(1), 23- 27.
|
[15]
|
Francis, C.W. (2002) Plasminogen activator inhibitor-1 levels and polymorphisms. Archives of Pathology & Laboratory Medicine, 126(11), 1401-1404.
|
[16]
|
Akar, N., et al. (2000) Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in turkish deep vein thrombotic patients with and without FV1691 G-A. Thrombosis Research, 97, 227-230.
|
[17]
|
Choudhury, N.A., Pietraszek, M.H., Hachiya, T., Baba, S., Sakaguchi, S., Takada, Y. and Takada, A. (1992) Plasminogen activators and plasminogen activator inhibitor 1 before and after venous occlusion of the upper limb in thromboangiitis obliterans (Buerger’s disease). Thrombosis Research, 66(4), 321-329.
|
[18]
|
Eroglu, A., Ulu, A. and Akar, N. (2006) Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients with and without thrombosis. Journal of Thrombosis and Thrombolysis, 22(2), 111-112.
|
[19]
|
Boekholdt, S.M., Bijsterveld, N.R., Moons, A.H., Levi, M., Büller, H.R. and Peters, R.J. (2001) Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: A systematic review. Circulation, 104(25), 3063-3068.
|
[20]
|
Ye, Z., Liu, E.H., Higgins, J.P., Keavney, B.D., Lowe, G.D., Collins, R. and Danesh J. (2006) Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66, 155 cases and 91,307 controls. Lancet, 367(9511), 651- 658.
|
[21]
|
Tsantes, A.E., Nikolopoulos, G.K., Bagos, P.G., Rapti, E., Mantzios, G., Kapsimali, V. and Travlou, A. (2007) Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis. Journal of Thrombosis and Haemostasis, 97(6), 907-913.
|